Literature DB >> 29396492

Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source Tools.

Shawn Minnig1, Robert M Bragg1, Hardeep S Tiwana1, Wes T Solem1, William S Hovander1, Eva-Mari S Vik1, Madeline Hamilton1, Samuel R W Legg1, Dominic D Shuttleworth1, Sydney R Coffey1, Jeffrey P Cantle1, Jeffrey B Carroll2.   

Abstract

Apathy is one of the most prevalent and progressive psychiatric symptoms in Huntington's disease (HD) patients. However, preclinical work in HD mouse models tends to focus on molecular and motor, rather than affective, phenotypes. Measuring behavior in mice often produces noisy data and requires large cohorts to detect phenotypic rescue with appropriate power. The operant equipment necessary for measuring affective phenotypes is typically expensive, proprietary to commercial entities, and bulky which can render adequately sized mouse cohorts as cost-prohibitive. Thus, we describe here a home-built, open-source alternative to commercial hardware that is reliable, scalable, and reproducible. Using off-the-shelf hardware, we adapted and built several of the rodent operant buckets (ROBucket) to test HttQ111/+ mice for attention deficits in fixed ratio (FR) and progressive ratio (PR) tasks. We find that, despite normal performance in reward attainment in the FR task, HttQ111/+ mice exhibit reduced PR performance at 9-11 months of age, suggesting motivational deficits. We replicated this in two independent cohorts, demonstrating the reliability and utility of both the apathetic phenotype, and these ROBuckets, for preclinical HD studies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29396492      PMCID: PMC5797185          DOI: 10.1038/s41598-018-20607-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

1.  Progressive ratio as a measure of reward strength.

Authors:  W HODOS
Journal:  Science       Date:  1961-09-29       Impact factor: 47.728

2.  Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease.

Authors:  Izelle Labuschagne; Rebecca Jones; Jenny Callaghan; Daisy Whitehead; Eve M Dumas; Miranda J Say; Ellen P Hart; Damian Justo; Allison Coleman; Rachelle C Dar Santos; Chris Frost; David Craufurd; Sarah J Tabrizi; Julie C Stout
Journal:  Psychiatry Res       Date:  2012-10-07       Impact factor: 3.222

3.  Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease.

Authors:  Sydney R Coffey; Robert M Bragg; Shawn Minnig; Seth A Ament; Jeffrey P Cantle; Anne Glickenhaus; Daniel Shelnut; José M Carrillo; Dominic D Shuttleworth; Julie-Anne Rodier; Kimihiro Noguchi; C Frank Bennett; Nathan D Price; Holly B Kordasiewicz; Jeffrey B Carroll
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

4.  A call for transparent reporting to optimize the predictive value of preclinical research.

Authors:  Story C Landis; Susan G Amara; Khusru Asadullah; Chris P Austin; Robi Blumenstein; Eileen W Bradley; Ronald G Crystal; Robert B Darnell; Robert J Ferrante; Howard Fillit; Robert Finkelstein; Marc Fisher; Howard E Gendelman; Robert M Golub; John L Goudreau; Robert A Gross; Amelie K Gubitz; Sharon E Hesterlee; David W Howells; John Huguenard; Katrina Kelner; Walter Koroshetz; Dimitri Krainc; Stanley E Lazic; Michael S Levine; Malcolm R Macleod; John M McCall; Richard T Moxley; Kalyani Narasimhan; Linda J Noble; Steve Perrin; John D Porter; Oswald Steward; Ellis Unger; Ursula Utz; Shai D Silberberg
Journal:  Nature       Date:  2012-10-11       Impact factor: 49.962

Review 5.  Animal models of Huntington's disease for translation to the clinic: best practices.

Authors:  Liliana Menalled; Daniela Brunner
Journal:  Mov Disord       Date:  2014-09-15       Impact factor: 10.338

6.  Automated deformation analysis in the YAC128 Huntington disease mouse model.

Authors:  Jason P Lerch; Jeffrey B Carroll; Shoshana Spring; Lisa N Bertram; Claudia Schwab; Michael R Hayden; R Mark Henkelman
Journal:  Neuroimage       Date:  2007-08-31       Impact factor: 6.556

Review 7.  The nosological position of apathy in clinical practice.

Authors:  S E Starkstein; A F G Leentjens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01-10       Impact factor: 10.154

Review 8.  The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation.

Authors:  Marina Papoutsi; Izelle Labuschagne; Sarah J Tabrizi; Julie C Stout
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

9.  Is a motor criterion essential for the diagnosis of clinical huntington disease?

Authors:  Clement T Loy; Elizabeth A McCusker
Journal:  PLoS Curr       Date:  2013-04-11

10.  Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.

Authors:  Peter Langfelder; Jeffrey P Cantle; Doxa Chatzopoulou; Nan Wang; Fuying Gao; Ismael Al-Ramahi; Xiao-Hong Lu; Eliana Marisa Ramos; Karla El-Zein; Yining Zhao; Sandeep Deverasetty; Andreas Tebbe; Christoph Schaab; Daniel J Lavery; David Howland; Seung Kwak; Juan Botas; Jeffrey S Aaronson; Jim Rosinski; Giovanni Coppola; Steve Horvath; X William Yang
Journal:  Nat Neurosci       Date:  2016-02-22       Impact factor: 24.884

View more
  3 in total

1.  Impaired Refinement of Kinematic Variability in Huntington Disease Mice on an Automated Home Cage Forelimb Motor Task.

Authors:  Cameron L Woodard; Marja D Sepers; Lynn A Raymond
Journal:  J Neurosci       Date:  2021-08-24       Impact factor: 6.167

2.  Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning Task.

Authors:  Tuukka O Piiponniemi; Teija Parkkari; Taneli Heikkinen; Jukka Puoliväli; Larry C Park; Roger Cachope; Maksym V Kopanitsa
Journal:  Front Behav Neurosci       Date:  2018-10-02       Impact factor: 3.558

3.  Age-Dependent Degradation of Locomotion Encoding in Huntington's Disease R6/2 Model Mice.

Authors:  Hagar G Yamin; Noa Menkes-Caspi; Edward A Stern; Dana Cohen
Journal:  J Huntingtons Dis       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.